SEAL Therapeutics AG develops its proprietary SEAL technology as potential gene therapy treatment of LAMA2-related congenital muscular dystrophy (LAMA2 MD)

ID: 1477631131013066753

linkhttp://www.sealtherapeutics.com calendar_today02-01-2022 13:22:27